Fundraising Fox
/Companies
Sign in

Quris

Boston, US · 6 known investors

Find your way into Quris

Sign up to see every warm intro you have to Quris

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Quris team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Quris develops a machine-learning platform for drug development, applying AI, engineering, and biology to predict how drugs will perform. The company works in the pharmaceutical and biotech space to improve how new drugs are tested and developed.

AI & Machine LearningBiotechHealthtech

Founders & leadership

IBIsaac Bentwich
Isaac BentwichFounder & CEOIsaac Bentwich is founder and CEO of Quris, which develops machine-learning tools for pharmaceutical drug development.
YH
Yossi HaranCo-Founder & CTO

Investors · 6

iAngelslisted by iAngelsTel Aviv

How we know: iAngels's portfolio page · press coverage · Not right? Tell us

iAngels Capitallisted by iAngels CapitalTel Aviv

How we know: iAngels Capital's portfolio page · Not right? Tell us

SoftBank Vision Fundlisted by SoftBank Vision FundLondon
Vox Capitallisted by Vox CapitalSão Paulo · $90K – $6M

How we know: Vox Capital's portfolio page · Not right? Tell us

Welltech Ventureslisted by Welltech VenturesTel Aviv

How we know: Welltech Ventures's portfolio page · a partner's Signal profile · press coverage · Not right? Tell us

Funding

SEC filings, press & company announcements

$28M disclosed across 1 of 3 rounds · 2021–2022

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 5

QuralisQurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms. The company was founded by neuroscientists from Harvard to translate emerging discoveries about disease pathways into treatment breakthroughs for ALS patients.
QureatorQureator develops non-animal testing methods for drug development, notably achieving an FDA IND approval without animal proof-of-concept data in collaboration with SillaJen. The company works in preclinical biotech, providing alternatives to animal testing for pharmaceutical partners.
Recursion PharmaceuticalsRecursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments. The company combines life scientists and software engineers to solve problems at the intersection of biology and technology.
AccuristechAccuris provides a searchable library of over 2.8 million engineering standards, regulations, and parts data, delivered through two platforms for engineering and supply chain intelligence. Its tools help engineers and supply chain teams maintain compliance, trace requirements, and manage component obsolescence risks across regulated industries such as aerospace, energy, automotive, medical devices, and government.
Curi BioCuri Bio provides a preclinical drug development platform combining 3D human tissue models of disease (cardiac and skeletal muscle), biosystems for functional analysis, and AI/ML-based insights to assess drug safety, efficacy, and potency. It serves pharmaceutical and biotech R&D teams working on drug discovery.

Companies working in the same space as Quris.

Frequently asked questions

What does Quris do?
Quris develops a machine-learning platform for drug development, applying AI, engineering, and biology to predict how drugs will perform. The company works in the pharmaceutical and biotech space to improve how new drugs are tested and developed.
Who founded Quris?
Quris was founded by Isaac Bentwich, Yossi Haran.
Who are Quris's investors?
Quris's investors include Fusion VC, iAngels, iAngels Capital, SoftBank Vision Fund, Vox Capital, Welltech Ventures.
How much funding has Quris raised?
Quris has disclosed $28M raised across 1 of its 3 known rounds.
Where is Quris headquartered?
Quris is headquartered in Boston, US.